1. Home
  2. SUPX vs HROW Comparison

SUPX vs HROW Comparison

Compare SUPX & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SUPX

Super X AI Technology Limited Ordinary Shares

HOLD

Current Price

$15.85

Market Cap

1.7B

Sector

N/A

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$48.42

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPX
HROW
Founded
2021
1998
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
SUPX
HROW
Price
$15.85
$48.42
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$68.86
AVG Volume (30 Days)
417.6K
508.8K
Earning Date
10-24-2025
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,596,575.00
$250,042,000.00
Revenue This Year
N/A
$38.86
Revenue Next Year
N/A
$42.16
P/E Ratio
N/A
N/A
Revenue Growth
23.88
47.83
52 Week Low
$3.79
$20.85
52 Week High
$76.50
$54.85

Technical Indicators

Market Signals
Indicator
SUPX
HROW
Relative Strength Index (RSI) 49.83 57.24
Support Level $13.75 $44.67
Resistance Level $18.80 $48.40
Average True Range (ATR) 2.40 2.06
MACD 0.47 0.44
Stochastic Oscillator 35.41 88.46

Price Performance

Historical Comparison
SUPX
HROW

About SUPX Super X AI Technology Limited Ordinary Shares

Super X AI Technology Ltd is an AI infrastructure solutions provider. Through its subsidiaries, SuperX offers a comprehensive portfolio of proprietary hardware, advanced software, and end-to-end services for AI data centers. The Company's services include advanced solution design and planning, cost-effective infrastructure product integration, and end-to-end operations and maintenance. Its core products include high-performance AI servers, High-Voltage Direct Current (HVDC) solutions, high-density liquid cooling solutions, as well as AI cloud and AI agents. The Company serves institutional clients globally, including enterprises, research institutions, and cloud and edge computing deployments.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: